USAID cuts shutter India's first clinic for transgender people
India's first medical clinic for transgender people has shut operations in three cities after US President Donald Trump stopped foreign aid to it.
Mitr (friend) Clinic, which was started in 2021 in the southern city of Hyderabad, offered HIV treatment, gender affirming support and counselling services to thousands of transgender people.
Two more Mitr Clinics in Thane and Pune cities in western India, which were established the same year, have also shut down due to the aid cut.
In January, Trump signed an executive order pausing all foreign aid for 90 days, pending a review.
Trump has said he wants overseas spending to be closely aligned with his "America First" approach.
His crackdown on USAID, the US agency overseeing humanitarian aid to foreign countries since the 1960s, has been seen as a step to this end.
The pausing of USAID funds has affected dozens of development programmes all around the world, especially in poor and developing countries.
In India, the shutting down of the Mitr Clinics has impacted the transgender community's access to crucial medical support.
The project came into existence under the US President's agency for AIDS Relief (PEPFAR) in 2003 when George Bush was president. John Hopkins University worked in collaboration with USAID and the Indian government to set it up.
A staff member who spoke on condition of anonymity to BBC Hindi said the three clinics catered to some 6,000 people and about 6% to 8% of the patients were being treated for HIV.
"All these cases were below 30 years of age. And 75% to 80% of this population was accessing health services for the first time," this staff member said.
In Hyderabad, the Mitr Clinic offered care to 150 to 200 transgender patients each month, many of whom suffered from HIV. The clinic had a small team of doctors, psychologists and technical staff.
"We were receiving 250,000 rupees ($2900; £2300) every month to provide services," Rachana Mudraboyina, a transwoman who was in-charge of the clinic, told BBC Hindi.
The news of the clinic's closure has come as a blow to the community.
Vyjayanti Vasanta Mogli, a transwoman who has visited the clinic, told The Indian Express newspaper that she was "devastated" by the news as the clinic used to offer treatment at subsidised rates.
Another transwoman, who was hoping to avail of the clinic's gender affirming services, told the Express that she was sad that she would no longer be able to do this.
India is estimated to have around two million transgender people, though activists say the number is higher. Despite a 2014 Supreme Court ruling that gives them the same rights as people of other genders, many still struggle to access education and healthcare due to stigma and discrimination.
There are state-run and private hospitals that offer medical help to the community, but many say they prefer going to Mitr Clinics because they find it more affordable and inclusive.
"Transgender people are not treated properly in general hospitals," Rachana says, explaining why the Mitr Clinics were so important for the community.
Trump's order freezing foreign aid has been criticised by many.
"USAID has made significant contributions in health and education and shutting it down is bound to have an impact on developing countries," Bubberjung Venkatesh, a lawyer, told BBC Hindi.
"It's a big blow. Its support for HIV prevention was significant," he added.
Last Thursday, the Trump administration said it was going to eliminate more than 90% of USAID's foreign aid contracts. This means that very few projects will survive and the Mitr Clinics are unlikely to be among them.
Elon Musk, a close aide of Trump who also heads a government department in charge of slashing federal spending and jobs, has criticised funding projects for transgender people.
"That's what American tax dollars were funding," Musk said in a post on X (formerly Twitter) on Friday in response to a post about the closure of the Mitr Clinics.
Meanwhile, staff at the clinic say they are looking for funding from other sources and hope that the state government will step in to help.
"We did a lot more than just provide medical help. The clinic also provided us a space to interact with the community, to share advice about various government schemes and health facilities," Rachana says.
"We want to continue [running the clinic] and are trying our best to find donors," she adds.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
26 minutes ago
- Yahoo
US lawmakers pass tougher penalties for fentanyl traffickers
The US Congress on Thursday passed a bill imposing harsher penalties on fentanyl traffickers, with lawmakers from both parties anxious to crack down on an opioid that has driven an epidemic of deadly overdoses. The Senate-passed bill -- which delivers on a key election pledge of President Donald Trump to get tough on drug smuggling -- was rubber-stamped by the House on a 321-104 vote, with Democrats providing all but one of the no votes. The Justice Department says 75,000 Americans die each year because of fentanyl, making it the number one cause of death for people between the ages of 18 and 34 in the United States. The synthetic opioid is more potent than heroin and much cheaper to produce. "More Americans die of drug overdoses each year than the number of Americans who died in the entirety of the Vietnam War," Republican Senate Majority Leader John Thune said ahead of the vote. The HALT Fentanyl Act places copycat variations of fentanyl -- often sold by traffickers -- on the government's list of most dangerous "Schedule 1" drugs alongside the original substance. Lab-created fentanyl alternatives were reclassified to "Schedule 1" on a temporary basis seven years ago but the vote makes the change permanent. Trump has made halting the flow of fentanyl one of his priorities, even announcing it as a justification for import tariffs on Mexico and Canada. But opponents said the new law -- rather than tackling overdoses -- would simply repeat the mistakes of the so-called "War on Drugs." The Leadership Conference on Civil and Human Rights, a coalition of more than 240 US rights organizations, said in a statement the measure would "exacerbate pretrial detention, mass incarceration, and racial disparities in the prison system." "Beginning in the 1980s, draconian drug laws with harsh mandatory minimums and their resulting enforcement under the banner of the 'war on drugs' fueled skyrocketing prison populations," it said. ft/acb
Yahoo
41 minutes ago
- Yahoo
Trump's former surgeon general rips RFK Jr.'s purge of vaccine board
President Trump's former surgeon general blasted Health and Human Services Secretary Robert F. Kennedy Jr.'s decision to fire the entirety of a federal advisory committee on vaccine guidance, saying the move jeopardizes public health and threatens public trust in health institutions. In an op-ed published by Time, former Surgeon General Jerome Adams wrote that Kennedy's recent actions cast doubt over his pledge that, 'We won't take away anyone's vaccines.' He pointed to the Food and Drug Administration's (FDA) new framework limiting access to COVID-19 vaccines; the Centers for Disease Control and Prevention (CDC) no longer recommending the shot for children and pregnant women; and the removal of members on the CDC's Advisory Committee on Immunization Practices (ACIP). 'These actions collectively restrict access to a vital tool for saving lives and undermine confidence in our health systems,' said Adams, who served in the Trump administration from 2017 to 2021. 'The major flaw in the new vaccine framework is its narrow assessment of risk. Although the immediate dangers of COVID-19 have lessened, it remains a leading cause of death and hospitalization, claiming nearly 50,000 lives in the U.S. in 2024 — more than breast cancer or car accidents,' he added. Kennedy announced Wednesday eight new members of the ACIP to replace the 17 that he had fired. Among the new members were noted spreaders of COVID-19 misinformation. As Endpoints News reported, two of the new picks were previously paid expert witnesses for plaintiffs in a lawsuit against Merck over its HPV and MMR vaccines. Kennedy had financial interests in the HPV vaccine lawsuit before divesting upon being confirmed. In his Thursday op-ed, Adams lamented that seniors and pregnant mothers are at a higher risk of severe COVID-19 outcomes, and the dismissal of the ACIP members only 'amplifies these concerns.' 'ACIP has been a trusted, science-driven body that ensures vaccines are safe and effective, saving countless lives through its transparent recommendations. Its members, rigorously vetted for expertise and conflicts of interest, provide independent guidance critical to public health,' he wrote. 'Removing them without clear evidence of misconduct risks replacing qualified scientists with less experienced voices.' In social media posts following his op-ed, Adams insinuated perjury had taken place, reposting epidemiologist and health economist Eric Feigl-Ding who said Kennedy's promises of not taking away vaccines were 'lies, damn lies.' 'No matter your stance on vaccines, or FDA, or CDC, reasonable and patriotic people should be able to agree that perjury (or even the appearance of intent to deceive Congress) is not an appropriate means to justify a desired end,' Adams said in the post on social platform X. Adams has shared criticisms, some veiled, of the Trump administration's actions and picks for key health positions in recent weeks. After Trump announced Casey Means as his new nominee for surgeon general, Adams took to social media to highlight Means's lack of credentials in comparison to prior surgeon generals such as himself. Writing on X earlier this month, Adams said, 'I do not know and have nothing against Dr. Means – but I feel strongly that the person who is leading America's Public Health Service should be held to the same standard as the people he or she is leading.' Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Associated Press
2 hours ago
- Associated Press
House passes bill to to combat fentanyl trafficking, sending it to Trump's desk
WASHINGTON (AP) — The House overwhelmingly passed bipartisan legislation Thursday that would solidify federal policies cracking down on the synthetic opioid fentanyl and its analogs in a bid by lawmakers to combat the nation's opioid epidemic. The HALT Fentanyl Act makes permanent a 2018 emergency rule that classifies knockoffs of fentanyl as Schedule I controlled substances, which results in harsher sentences for possession of the drug. The bill passed the House 321-104 and now heads to President Donald Trump for his signature. The legislation, which applies to what are known as known as 'fentanyl-related substances,' garnered support from nearly every Republican and many Democrats despite concerns that the bill does not address the root issues at hand and will add to problems in the criminal justice system. Senate Majority Leader John Thune hailed passage of the bill and promised more legislative action to come. 'I don't need to tell anybody about the horrible impact of drug overdoses in this country, many of them caused by fentanyl,' Thune said on the Senate floor. 'In the coming weeks, we'll be taking up legislation to address another aspect of the fight: securing our borders,' a nod to Republicans' tax package, which includes billions of dollars in additional immigration enforcement and border security funding. Proponents of the legislation argue that the bill will make it easier to stop drug traffickers by making the federal emergency rules permanent. Opponents say the framework does little to stem the epidemic and warn it will make it harder to conduct important research. Congress has regularly renewed the emergency rules since 2018, meaning there is no immediate change to federal policy. The bill does not include increased funding for law enforcement to conduct anti-drug trafficking efforts, nor funding for public health efforts meant to reduce fentanyl addiction and deaths. The bill's supporters say that the reclassification will give anti-trafficking efforts clearer standards to operate under as law enforcement combats the trade. Federal, state and local law enforcement have sought to break up the flow of fentanyl into the U.S. by targeting Mexican drug cartels and local gangs. The Trump administration has declared stemming the flow of fentanyl precursors from China a priority in trade talks with Beijing, an effort that follows a spate of initiatives by the Biden administration to reduce the importation of such substances into the U.S. from China and other illegal supply chains. 'A loophole that the cartels have tried to use to drive their illicit fentanyl into our country is by changing one part of the fentanyl chemical structure to create fentanyl analogs,' said GOP Virginia Rep. Morgan Griffith, one of the bill's co-sponsors, during Wednesday's debate on the House floor. 'The cartels did this in an attempt to evade our criminal laws,' said Griffith, who argued that the bill would help prevent further fentanyl deaths and increase the potential for research into the drug and related substances. And lawmakers appealed to the human cost of fentanyl smuggling. 'We must give our law enforcement the tools to combat this problem. This bill does exactly that,' said GOP California Rep. Jay Obernolte, a co-sponsor of the bill. Obernolte recounted the stories of families impacted by fentanyl overdoses in his district and noted that more than 100,000 Americans died of an overdose last year, mostly from fentanyl. The bill 'gives our law enforcement agencies the tools that they need to begin dealing with this problem,' Obernolte said. Democratic New Jersey Rep. Frank Pallone said during debate that he opposed the bill because it uniformly criminalizes fentanyl related substances. Pallone said it will impede potential research into their benefits rather than provide an 'offramp to substances found to have potential medical applications.' Pallone also chided Republicans for saying they aimed to tackle the opioid epidemic while supporting the Trump administration's cuts to federal agencies tasked with research and public health policy. 'This Republican bill would also exacerbate inequities in our criminal justice system because drugs placed on Schedule I include mandatory minimum sentencing,' Pallone said. 'The bill is essentially recycling an incarceration first response to what I consider mainly a public health challenge.' Schedule I drugs are substances considered by the Drug Enforcement Agency to have 'no currently accepted medical use and a high potential for abuse.' Possession of a Schedule I drug is considered a felony and can be prosecuted as drug smuggling. Drugs currently classified as Schedule I include heroin, marijuana and methaqualone. Fentanyl itself is classified as a Schedule II drug, which the DEA designates as having 'a high potential for abuse.' Schedule II substances include cocaine, methamphetamine, oxycodone and Adderall.
